M.B.X. Biosciences (MBX)
Develops precision peptide therapies for endocrine and metabolic disorders.
$58.75
vs last close−3.23 (−5.21%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$0.83
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.47−$0.71−$0.58−$0.63−$0.49−$0.51−$0.78Pending
Estimate−$0.59−$0.81−$0.77−$0.73−$0.64−$0.62−$0.63−$0.83
Surprise+20.3%+12.3%+24.7%+13.7%+23.4%+17.7%−23.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.05 | — | — |
| Sep 2027 | −$0.99 | — | — |
| Jun 2027 | −$0.96 | — | — |
| Mar 2027 | −$0.92 | — | — |
| Dec 2026 | −$0.94 | — | — |
| Nov 2026 | −$0.83 | — | — |
| Aug 2026 | −$0.63 | −$0.78 | −23.3% |
| May 2026 | −$0.62 | −$0.51 | +17.7% |
| Mar 2026 | −$0.64 | −$0.49 | +23.4% |
| Nov 2025 | −$0.73 | −$0.63 | +13.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Sep 2024 | — | — | — |
| Aug 2024 | |||
| Dec 2023 | |||
| Sep 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.05 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.99 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.96 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.92 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.94 | — | — | $0 | — | — | — |
| Nov 5, 2026 | −$0.83 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.63 | −$0.78 | −23.3% | — | — | — | −0.6% |
| May 7, 2026 | −$0.62 | −$0.51 | +17.7% | — | — | — | +8.1% |
| Mar 12, 2026 | −$0.64 | −$0.49 | +23.4% | — | — | — | −3.4% |
| Nov 6, 2025 | −$0.73 | −$0.63 | +13.7% | — | — | — | +9.7% |
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 17, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Sep 13, 2024 | — | — | — | — | — | — | — |
| Aug 23, 2024 | |||||||
| Dec 31, 2023 | |||||||
| Sep 30, 2023 |